Piramal Pharma Limited (PPLPHARMA) — Financial Flexibility Index
Piramal Pharma Limited (PPLPHARMA) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of Rs13.23 Billion (operating CF Rs8.90 Billion minus capex Rs4.33 Billion) represents 0% of total liabilities (Rs81.16 Billion). Also explore Piramal Pharma Limited equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Piramal Pharma Limited Financial Flexibility Index (2021–2026)
Historical Financial Flexibility Index trend for Piramal Pharma Limited across 6 annual periods. Check Piramal Pharma Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Piramal Pharma Limited (2021–2026)
Year-by-year free cash flow to debt coverage for Piramal Pharma Limited. For the full company profile including market capitalisation, see PPLPHARMA market cap.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.23x | Rs22.90 Billion | Rs14.00 Billion | Rs98.02 Billion | ▲ +13.3% |
| 2025 | 0.21x | Rs15.57 Billion | Rs8.92 Billion | Rs75.52 Billion | ▼ -11.1% |
| 2024 | 0.23x | Rs17.17 Billion | Rs10.05 Billion | Rs74.00 Billion | ▲ +24.1% |
| 2023 | 0.19x | Rs14.49 Billion | Rs4.84 Billion | Rs77.49 Billion | ▲ +150.3% |
| 2022 | 0.07x | Rs4.56 Billion | Rs2.55 Billion | Rs61.00 Billion | ▲ +33.3% |
| 2021 | 0.06x | Rs928.30 Million | Rs347.20 Million | Rs16.56 Billion | — |